Hypomelanotic Disorder Overview

Save information for later
Sign Up

Learn About Hypomelanotic Disorder

What is the definition of Hypomelanotic Disorder?
Hypomelanotic disorder is a term that refers to types of skin conditions in which melanocytes (pigment cells) have a loss of pigment. Types of hypomelanotic disorders include vitiligo, ash leaf spots, and idiopathic guttate hypomelanosis, among others.
What are the symptoms of Hypomelanotic Disorder?
Symptoms of hypomelanotic disorders include loss of pigmentation that varies by the type of disorder. Symptoms of vitiligo include a complete loss of pigment in the skin that appears as well-delineated spots and patches. Symptoms of ash leaf spots include oval flattened areas of skin that lack pigment and angiofibromas on the face. Symptoms of idiopathic guttate hypomelanosis include small white flattened areas on sun-exposed skin areas.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Hypomelanotic Disorder?
Treatment for hypomelanotic disorders depends on the type. Treatment for vitiligo may include corticosteroids, tacrolimus, pimecrolimus, ultraviolet B and PUVA therapy, self-tanning creams, and skin grafting. Treatment for ash leaf spots may include laser therapy. Treatment for idiopathis guttate hypomelanosis is not necessary.
Who are the top Hypomelanotic Disorder Local Doctors?
Dr. Seema P. Apichai
Dermatology
Dr. Seema P. Apichai
Dermatology

Beaird Dermatology Sc

4885 Hoffman Blvd, 
Hoffman Estates, IL 
 (4.9 mi)
224-484-0183
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Seema Apichai is a Dermatologist in Hoffman Estates, Illinois. Dr. Apichai and is rated as an Advanced provider by MediFind in the treatment of Hypomelanotic Disorder. Her top areas of expertise are Actinic Keratosis, Basal Cell Skin Cancer, Bowen's Disease, and Neurocutaneous Melanosis. Dr. Apichai is currently accepting new patients.

Dr. Patricia A. Ledwig
Dermatology
Dr. Patricia A. Ledwig
Dermatology
2500 W. Higgins Road, Suite 1040, 
Hoffman Estates, IL 
 (7.4 mi)
847-884-8096
Languages Spoken:
English

Patricia Ledwig is a Dermatologist in Hoffman Estates, Illinois. Dr. Ledwig and is rated as an Advanced provider by MediFind in the treatment of Hypomelanotic Disorder. Her top areas of expertise are Dyschromatosis Symmetrica Hereditaria, Griscelli Syndrome, Hypomelanotic Disorder, and Dyschromatosis Universalis Hereditaria.

 
 
 
 
Learn about our expert tiers
Learn More
Dr. Sanjeev M. Gupta
Internal Medicine
Dr. Sanjeev M. Gupta
Internal Medicine

Advocate Medical Group

525 East Congress Parkway, Suite 350, 
Crystal Lake, IL 
 (13.8 mi)
815-479-7490
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Sanjeev Gupta is an Internal Medicine provider in Crystal Lake, Illinois. Dr. Gupta and is rated as a Distinguished provider by MediFind in the treatment of Hypomelanotic Disorder. His top areas of expertise are Low Sodium Level, Hypomelanotic Disorder, Vitiligo, Hepato-Pancreato-Biliary Surgery, and Trabeculectomy. Dr. Gupta is currently accepting new patients.

View All Doctors
What are the latest Hypomelanotic Disorder Clinical Trials?
A Phase 3, Randomized, Double-Blind, 52-Week, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib in Participants With Nonsegmental Vitiligo
A Phase 3, Randomized, Double-Blind, 52-Week, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib in Participants With Nonsegmental Vitiligo
Enrollment Status: Recruiting
Publish Date: February 21, 2025
Intervention Type: Drug
Study Phase: Phase 3

Summary: This study is being conducted to determine the efficacy and safety of povorcitinib in participants with nonsegmental vitiligo.

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 3, Randomized, Double-Blind, Safety, and Efficacy Study of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
A Phase 3, Randomized, Double-Blind, Safety, and Efficacy Study of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
Enrollment Status: Recruiting
Publish Date: February 21, 2025
Intervention Type: Drug
Study Phase: Phase 3

Summary: The purpose of this study is to to evaluate the safety and efficacy of ruxolitinib cream in pediatric participants with nonsegmental vitiligo.

View All Clinical Trials